Second-generation adenovirus vectors

Nature Medicine

Volumn 2, Issue 6, 1996, Pages 714-716

  Wang, Qing ^a   Finer, Mitchell H ^a  

^a CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ADENOVIRUS; CHEMISTRY; FORECASTING; GENE TRANSFER; GENE VECTOR; GENETICS; REVIEW;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; ADENOVIRUS E2 PROTEINS; ADENOVIRUS E4 PROTEINS; FORECASTING; GENE TRANSFER TECHNIQUES; GENETIC VECTORS;

EID: 0030161017     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0696-714     Document Type: Article

References (18)

1. Yang, N-S. Gene transfer into mammalian somatic cells in vivo. Critical Rev. Biotech. 12, 335-356 (1992).
2. Kozarsdy, K.F. & Wilson, J.M. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Devel. 3, 499-503 (1993).
3. Jones, N. & Shenk, T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation in rat embryo cells. Cell 17, 683-689 (1979).
4. Reichel, R., Kovesdi, I., Kevins, M. Jr. Developmental control of a promoter-specific factor that is also regulated by the E1A gene product. Cell 48, 501-506 (1987).
5. Zhang, Y. & Schneider, R.J. Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J. Virol. 68, 2544-2555 (1994).
6. Valentine, R.C. & Pereira, H.G. Antigens and structure of the adenovirus. J. Mol. Biol. 13, 13-20 (1965).
7. Lochmuller, H.J. et al. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491 (1994).
8. Yang, Y. et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411 (1994).
9. Yang, Y., Ertl, H.C.J. & Wilson, J.M. MHC class1-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442 (1994).
10. Flint, J. & Broker, T.R. Lytic infections by adenoviruses in Molecular Biology of Tumor Viruses: DNA Tumor Viruses 2nd edn. (ed. Tooze, J.) 443-454 (Cold Spring Harbor Laboratory, 1980).
11. Engelhardt, J.F., Ye, X., Doranz, B. & Wilson, J.M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200 (1994).
12. Golkman, M.J., Litzky, L.A., Engelhardt, J.F. & Wilson J.M. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study. Hum. Gene Ther. 6, 839-851 (1995).
13. Horwitz, M.S. Adenovirudae and their replication in Virology 2nd edn (ed. Fields, B.N. et al.) 1679-1721 (Raven Press, New York, 1994).
14. Fang, B. et al. Lack of persistence of E1-recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther. 3, 217-222 (1996).
15. Hrisse, J. & Rigolet, M., Dupont de Dinechin, S. & Gaubert, F. Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the entire E4 region. Nucleic Acid Res. 9, 4022-4042 (1981).
16. Sandler, A.B. & ketner, G. Adenovirus early region 4 is essential for normal stability of late nuclear RNAs. J. Virol. 63, 624-630 (1989).
17. Halbert, D.N., Cutt, J.R. & Shenk, T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56, 250-257 (1985).
18. Weinberg, D.H. & Ketner, G. Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J. Virol. 57, 833-838 (1986).